(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 4.86% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 3.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.87%.
Sotera Health Co's revenue in 2024 is $1,049,288,000.On average, 3 Wall Street analysts forecast SHC's revenue for 2024 to be $311,189,804,869, with the lowest SHC revenue forecast at $308,881,045,620, and the highest SHC revenue forecast at $313,030,193,994.
In 2025, SHC is forecast to generate $333,334,717,632 in revenue, with the lowest revenue forecast at $328,594,449,960 and the highest revenue forecast at $335,721,821,400.